Question 1

What is the catalog number for PLLA2000-PEG3000-RhB?

Accepted Answer

The catalog number for PLLA2000-PEG3000-RhB is orb3026636.

Question 2

What sizes are available for PLLA2000-PEG3000-RhB?

Accepted Answer

PLLA2000-PEG3000-RhB is available in the following size(s): 100 mg, 50 mg, 250 mg.

Question 3

How many pack sizes does PLLA2000-PEG3000-RhB come in?

Accepted Answer

PLLA2000-PEG3000-RhB is available in 3 different pack sizes.

Question 4

Is PLLA2000-PEG3000-RhB in stock?

Accepted Answer

PLLA2000-PEG3000-RhB is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is PLLA2000-PEG3000-RhB used for?

Accepted Answer

PLLA2000-PEG3000-RhB is a polylactic acid derivative with terminal rhodamine labeling. It can be utilized to label nanomicelles, allowing for the real-time monitoring of drug release in vivo.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 8

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

PLLA2000-PEG3000-RhB

Product Specifications

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

CD72 (B Cell Differentiation Antigen CD72, Lyb-2, LYB2) (HRP)

CD72 (B Cell Differentiation Antigen CD72, Lyb-2, LYB2) (HRP)

IPP-2 (Phospho Ser44) Polyclonal Antibody

IPP-2 (Phospho Ser44) Polyclonal Antibody

IPP-2 (Phospho Ser44) Polyclonal Antibody

Research Grade Plonmarlimab